<SEC-DOCUMENT>0001193125-25-156440.txt : 20250708
<SEC-HEADER>0001193125-25-156440.hdr.sgml : 20250708
<ACCEPTANCE-DATETIME>20250708081911
ACCESSION NUMBER:		0001193125-25-156440
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250708
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250708
DATE AS OF CHANGE:		20250708

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RECURSION PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001601830
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				464099738
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40323
		FILM NUMBER:		251109568

	BUSINESS ADDRESS:	
		STREET 1:		41S RIO GRANDE STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84101
		BUSINESS PHONE:		(385) 269-0203

	MAIL ADDRESS:	
		STREET 1:		41S RIO GRANDE STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Recursion Pharmaceuticals, LLC
		DATE OF NAME CHANGE:	20140305
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d83626d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rxrx="http://www.recursion.com/20250708" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-257">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-07-08_to_2025-07-08">0001601830</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="rxrx-20250708.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-07-08_to_2025-07-08"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-07-08</xbrli:startDate> <xbrli:endDate>2025-07-08</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-268">8-K</ix:nonNumeric></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-07-08_to_2025-07-08" format="ixt:datemonthdayyearen" id="ixv-269">July 8, 2025</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-270">RECURSION PHARMACEUTICALS, INC.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-07-08_to_2025-07-08" format="ixt-sec:stateprovnameen" id="ixv-271">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-272">001-40323</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-273">46-4099738</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-274">41 S Rio Grande Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-275">Salt Lake City</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-276">UT</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-277">84101</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-278">(385)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-279">269 - 0203</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-07-08_to_2025-07-08" format="ixt-sec:boolballotbox" id="ixv-280">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-07-08_to_2025-07-08" format="ixt-sec:boolballotbox" id="ixv-281">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-07-08_to_2025-07-08" format="ixt-sec:boolballotbox" id="ixv-282">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-07-08_to_2025-07-08" format="ixt-sec:boolballotbox" id="ixv-283">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-284">Class&#160;A Common Stock, par value $0.00001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-285">RXRX</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-07-08_to_2025-07-08" format="ixt-sec:exchnameen" id="ixv-286">Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-07-08_to_2025-07-08" format="ixt-sec:boolballotbox" id="ixv-287">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;3.02. Unregistered Sales of Equity Securities. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;8, 2025, Recursion Pharmaceuticals, Inc. (the &#8220;Company&#8221;), Exscientia Ventures I, Inc., an indirect wholly-owned subsidiary of the Company (&#8220;Buyer Sub&#8221;), Rallybio Corporation (&#8220;Rallybio&#8221;), and Rallybio IPB, LLC, a wholly-owned subsidiary of Rallybio (the &#8220;Seller&#8221;), entered into a Membership Interest Purchase Agreement (the &#8220;Purchase Agreement&#8221;). Pursuant to the Purchase Agreement, on July&#160;8, 2025, Buyer Sub acquired 50% of the issued and outstanding membership interests (the &#8220;Membership Interests&#8221;) of RE Ventures I, LLC (&#8220;ENPP1 JV&#8221;) from the Seller in exchange for cash and shares of Class&#160;A common stock of the Company (the &#8220;Shares&#8221;) as further described below (the &#8220;Acquisition&#8221;). Prior to the closing of the Acquisition, the Company indirectly held 50% of the membership interests of ENPP1 JV. As a result of the Acquisition, ENPP1 JV is an indirect wholly-owned subsidiary of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the Purchase Agreement, as partial consideration for the Acquisition, on July 8, 2025, the Company paid the Seller 1,457,952&#160;Shares (the &#8220;Initial Shares&#8221;), calculated by dividing $7,500,000 by a per share price of $5.1442, which is the volume weighted average price of the Class A common stock of the Company over the seven consecutive trading days ending on July&#160;7, 2025, the last trading day before the execution of the Purchase Agreement, and additional cash consideration in the amounts set forth in the Purchase Agreement. In addition, under the terms of the Purchase Agreement, as additional contingent consideration for the Acquisition, if certain milestones with respect to the compound developed by the ENPP1 JV are satisfied, the Company agreed to pay a number of Shares equal to the quotient obtained by dividing $12,500,000 by the volume weighted average price of the Class&#160;A common stock of the Company over the seven consecutive trading days ending on the day prior to the date the milestone is met (the &#8220;Contingent Shares&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreement further provides that notwithstanding anything to the contrary, the aggregate number of Shares that the Company may issue in connection with all payments under the Purchase Agreement shall not exceed 19.9% of (i) the aggregate total of shares of the Company&#8217;s Class&#160;A Common Stock and the Company&#8217;s Class&#160;B Common Stock outstanding on July&#160;7, 2025 or (ii)&#160;the aggregate total of shares of the Company&#8217;s Class&#160;A Common Stock and the Company&#8217;s Class&#160;B Common Stock outstanding the date immediately preceding the date of issuance of any Shares issued pursuant to the Purchase Agreement, whichever is less (the &#8220;Share Maximum&#8221;). To the extent any issuance of equity consideration required to be made to the Seller under the Purchase Agreement would exceed the Share Maximum, such payments will be made in cash. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreement also provides that the Company will make additional cash payments to the Seller contingent upon the occurrence of certain future events, including based on the amount of the proceeds received by the Seller from the sale of the Initial Shares and the Contingent Shares under certain circumstances and the occurrence of certain milestones or other events with respect to the compound developed by the ENPP1 JV. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has agreed to use commercially reasonable efforts to, as promptly as practicable, following the issuance to the Seller of Shares under the Purchase Agreement, file a registration statement (or if the Company is a well-known seasoned issuer as of the filing date, an automatic shelf registration statement or a prospectus supplement to an effective automatic shelf registration statement that will become effective upon filing with the SEC pursuant to Rule&#160;462(e)) with the Securities and Exchange Commission (the </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#8220;SEC&#8221;) providing for the resale by the Seller of such issued Shares. After such registration, the Company has agreed to use commercially reasonable efforts to keep such registration statement effective, subject to limited exceptions, until such date that all Shares covered by such registration statement have been sold thereunder or may be sold without restriction or volume limitation under Rule 144 as promulgated by the SEC under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based in part upon the representations of the Seller in the MIPA, the offering and sale of the Shares was made in reliance on the exemption afforded by Section&#160;4(a)(2) of the Securities Act and corresponding provisions of state securities or &#8220;blue sky&#8221; laws. The Shares have not been registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from the registration requirements. The sale of the Shares did not involve a public offering and was made without general solicitation or general advertising. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither this Current Report on Form <span style="white-space:nowrap">8-K</span> nor any exhibit attached hereto is an offer to sell or the solicitation of an offer to buy shares of Class&#160;A common stock or other securities of the Company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;7.01. Regulation FD Disclosure. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On&#160;July&#160;8, 2025, the Company issued a press release announcing the Acquisition. The press release is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and incorporated into this Item 7.01 by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information furnished pursuant to this Item 7.01, including Exhibit 99.1, on this Form <span style="white-space:nowrap">8-K,</span> shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;8.01. Other Events. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;8, 2025, the Company filed a prospectus supplement dated July&#160;8, 2025 (the &#8220;Prospectus Supplement&#8221;) and an accompanying base prospectus, which are part of Recursion&#8217;s automatic &#8220;shelf&#8221; Registration Statement on Form <span style="white-space:nowrap">S-3ASR</span> (File <span style="white-space:nowrap">No.&#160;333-284878)</span> (the &#8220;Registration Statement&#8221;), which was previously filed on February&#160;12, 2025 with the Securities and Exchange Commission (the &#8220;SEC&#8221;). The Prospectus Supplement was filed to register for resale 1,457,952 Shares that were issued as the Initial Shares under the Purchase Agreement as further described in Item 3.02 above, which is incorporated herein by reference. The offering of the Shares was made pursuant to an exemption from registration under the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the opinion of Wilson Sonsini Goodrich&#160;&amp; Rosati, P.C. relating to the legality of the Shares is filed herewith as Exhibit 5.1. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forward Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company cautions you that statements contained in this report includes or is based upon &#8220;forward-looking statements&#8221; within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding all actions and obligations under the Purchase Agreement, and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements such as those described under the heading &#8220;Risk Factors&#8221; in the Company&#8217;s filings with the SEC, including the Company&#8217;s most recent Annual Report on Form <span style="white-space:nowrap">10-K</span> and all subsequently filed Quarterly Reports on Form <span style="white-space:nowrap">10-Q.</span> The Company undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;9.01. Financial Statements and Exhibits. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center">Exhibit&#160;No.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Description</td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d83626dex51.htm">Opinion of Wilson Sonsini Goodrich&#160;&amp; Rosati, P.C. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d83626dex51.htm">Consent of Wilson Sonsini Goodrich&#160;&amp; Rosati, P.C. (included in Exhibit&#160;5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d83626dex991.htm">Press Release issued by the Company dated July&#160;8, 2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on July&#160;8, 2025. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">RECURSION PHARMACEUTICALS, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nathan Hatfield</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Nathan Hatfield</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Legal Officer</td></tr>
</table></div> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d83626dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">


<IMG SRC="g83626g99t49.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">Wilson Sonsini Goodrich&nbsp;&amp; Rosati</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">Professional Corporation</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">95 South State
Street, Suite 1000</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">Salt Lake City, UT 84111</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">T: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">801-401-8510</FONT></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">July&nbsp;8, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recursion Pharmaceuticals, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">41 S. Rio Grand St. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Salt Lake City, Utah 84101 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At your request, we have
examined the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3ASR</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-284878)</FONT> (the &#147;Registration Statement&#148;), including the prospectus dated February&nbsp;12,
2025 included therein (the &#147;Base Prospectus&#148;), filed by Recursion Pharmaceuticals, Inc., a Delaware corporation (the &#147;Company&#148;), with the Securities and Exchange Commission (the &#147;Commission&#148;) in connection with the
registration pursuant to the Securities Act of 1933, as amended (the &#147;Act&#148;), of the Securities (as defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Registration Statement relates to the proposed offer and sale by the selling stockholder (the &#147;Selling Stockholder&#148;), from time to time, pursuant to Rule 415 under the Act, as set forth in the Registration Statement, the Base Prospectus
and a prospectus supplement dated as of July&nbsp;8, 2025 (the &#147;Prospectus Supplement&#148; and together with the Base Prospectus, the &#147;Prospectus&#148;), of up to an aggregate of 1,457,952 shares of the Company&#146;s Class&nbsp;A common
stock, $0.00001 par value per share (the &#147;Securities&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Securities are to be sold from time to time as set forth in the
Registration Statement and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have examined instruments, documents, certificates and records that we have deemed relevant
and necessary for the basis of our opinions hereinafter expressed. In such examination, we have assumed: (a)&nbsp;the authenticity of original documents and the genuineness of all signatures; (b)&nbsp;the conformity to the originals of all documents
submitted to us as copies; (c)&nbsp;the truth, accuracy and completeness of the information, representations and warranties contained in the instruments, documents, certificates and records we have reviewed; (d)&nbsp;that the Registration Statement,
and any amendments thereto (including post-effective amendments), will have become effective under the Act; (e)&nbsp;that the Prospectus Supplement will have been filed with the Commission describing the Securities offered thereby; (f)&nbsp;that the
Securities will be sold in compliance with applicable U.S. federal and state securities laws and in the manner stated in the Registration Statement and the Prospectus; and (g)&nbsp;the legal capacity of all natural persons. As to any facts material
to the opinions expressed herein that were not independently established or verified, we have relied upon oral or written statements and representations of officers and other representatives of the Company. </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">AUSTIN&#8195;&#8195;&#8195;BOSTON&#8195;&#8195;&#8195;BOULDER&#8195;&#8195;&#8195;BRUSSELS&#8195;&#8195;&#8195;HONG
KONG&#8195;&#8195;&#8195;LONDON&#8195;&#8195;&#8195;LOS ANGELES&#8195;&#8195;&#8195;NEW YORK&#8195;&#8195;&#8195;PALO ALTO </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">SALT LAKE
CITY&#8195;SAN DIEGO&#8195;&#8195;&#8195;&#8195;SAN FRANCISCO&#8195;&#8195;&#8195;&#8195;SEATTLE&#8195;&#8195;&#8195;&#8195;SHANGHAI&#8195;&#8195;&#8195;&#8195;WASHINGTON, DC&#8195;&#8195;&#8195;&#8195;WILMINGTON, DE </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g83626g0707151441952.jpg" ALT="LOGO" STYLE="width:0.686806in;height:0.253472in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recursion Pharmaceuticals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">July&nbsp;8, 2025 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on such examination, we are of the opinion that the Securities are duly authorized,
validly issued, fully paid and nonassessable. It is understood that this opinion is to be used only in connection with the offer and resale of the Securities while the Registration Statement is in effect. We assume no obligation to supplement this
opinion if any applicable law changes after the date hereof or if we become aware of any fact that might change the opinion expressed herein after the date hereof. We express no opinion as to the laws of any other jurisdiction, other than the
federal laws of the United States of America and the General Corporation Law of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the use of this opinion as an exhibit to the Company&#146;s Current Report on Form
<FONT STYLE="white-space:nowrap">8-K,</FONT> filed on or about July&nbsp;8, 2025, for incorporation by reference into the Registration Statement and the Prospectus. In giving such consent, we do not thereby admit that we are in the category of
persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Sincerely, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">/s/ Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">WILSON SONSINI GOODRICH&nbsp;&amp; ROSATI </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Professional Corporation </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d83626dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recursion Acquires Full Rights to REV102, a Potential <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">First-in-Class</FONT></FONT> Oral
ENPP1 Inhibitor for Hypophosphatasia </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SALT LAKE CITY, July</B><B></B><B>&nbsp;8, 2025</B> &#150; Recursion (NASDAQ: RXRX) a leading clinical stage
TechBio company decoding biology to radically improve lives today announced the acquisition of Rallybio&#146;s (NASDAQ: RLYB) full interest in their joint ENPP1 inhibitor program (REV102) and an associated backup molecule for the treatment of
hypophosphatasia (HPP), a rare and debilitating genetic disorder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We extend our sincere thanks to Rallybio for their invaluable partnership in
advancing this program to its current stage,&#148; said David Hallett, Chief Scientific Officer of Recursion. &#147;Having full ownership of this important program allows Recursion to accelerate the development of the first potential oral
disease-modifying treatment to HPP patients, who currently face significant challenges with limited access to existing therapies. While this is a preclinical asset that will require further study, we look forward to leveraging the full power of the
Recursion OS to gain even deeper insights and accelerate delivery of the potential treatment.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The Rallybio team has long been committed to
targeting ENPP1 to address a significant unmet need in patients with HPP. By combining Rallybio&#146;s expertise in HPP preclinical and translational research with Recursion&#146;s integrated AI/experimental platform, we transformed this concept
into the first potential oral disease-modifying treatment for HPP,&#148; said Stephen Uden, M.D., Chief Executive Officer of Rallybio. &#147;We look forward to the advancement of REV102 through key milestones and, ultimately, to the delivery of this
important treatment to patients in need.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About REV102: ENPP1 Inhibitor Program for Hypophosphatasia (HPP) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The REV102 program targets ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), an enzyme implicated in the pathogenesis of HPP. The mechanism of action
involves a potent, highly selective inhibition of ENPP1, aiming to restore the crucial balance of inorganic pyrophosphate (PPi) necessary for proper bone mineralization, thereby addressing the underlying cause of HPP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HPP is a devastating genetic disorder affecting over 7,800 diagnosed patients across the US and EU5, many of whom have limited access to current Enzyme
Replacement Therapies (ERTs). Advancing REV102 presents a significant opportunity to not only provide a more accessible treatment but also to potentially reduce the substantial costs associated with long-term HPP management. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This candidate is designed to potentially be the first oral disease-modifying therapy for HPP, potentially offering an advantage in convenience and patient
quality of life over injectable treatments. Furthermore, as a preliminarily <FONT STYLE="white-space:nowrap">non-immunogenic</FONT> small molecule, this candidate could potentially offer a safer profile compared to biological ERTs, which can
sometimes induce immune responses. <B> </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AI enabled Design and Development </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The program originated from a joint venture with Rallybio, with Recursion leading the precision design of REV102. The Recursion OS&nbsp;&#151; an integrated
AI/experimental platform&nbsp;&#151; was used to optimize for potency, selectivity, and PK/PD properties suitable for chronic dosing, enabling a candidate with potential
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> characteristics. Early preclinical data has demonstrated a favorable safety profile in animal models and validated ENPP1 as a druggable target in
later-onset HPP. REV102 is currently in <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies, with the initiation of Phase 1 clinical trials expected in the second half of 2026. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Terms of the Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement,
Rallybio is eligible to receive certain payments, including $7.5&nbsp;million in upfront equity, a contingent equity payment of $12.5&nbsp;million upon the initiation of additional preclinical studies, and a $5&nbsp;million milestone payment in
connection with the initiation of dosing in a Phase 1 clinical study, as defined in the agreement. Rallybio is also eligible to receive low single-digit royalties on all future net sales by Recursion. In addition, Rallybio may be eligible to receive
certain payments in the event of Recursion&#146;s sale of the REV102 program. <B> </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Recursion </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the
Recursion OS, a platform built across diverse technologies that continuously expands one of the world&#146;s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its
dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale&nbsp;&#151; up to millions of wet lab experiments weekly &#151; and massive
computational scale&nbsp;&#151; owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, and chemistry to advance the future of medicine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices
in Montr&eacute;al, New York, London, and the Oxford area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document contains information that includes or is based upon &#147;forward-looking statements&#148; within the meaning of the Securities Litigation Reform
Act of 1995, including, without limitation, those regarding the potential efficacy of REV102, including the potential to be the first oral disease-modifying therapy for HPP patients; the potential acceleration of development of the REV102 program;
the impact of the Recursion OS on the program, including the potential to gain deeper insights and accelerate delivery of the treatment; the impact of <FONT STYLE="white-space:nowrap">pre-clinical</FONT> data on trial outcomes; the potential size of
the market opportunity; the timing of initiation of clinical trials; and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as &#147;plan,&#148; &#147;will,&#148;
&#147;expect,&#148; &#147;anticipate,&#148; &#147;intend,&#148; &#147;believe,&#148; &#147;potential,&#148; &#147;continue,&#148; and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual
results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs,
where the risk of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors; our ability to leverage and enhance our drug discovery platform;
our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates; our ability to obtain,
maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; and other risks and uncertainties such as those
described under the heading &#147;Risk Factors&#148; in our filings with the U.S. Securities and Exchange Commission, including our most recent Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K.</FONT> All forward-looking statements are based on management&#146;s current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a
result of new information, future developments, or otherwise, except to the extent required by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Media Contact </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Media@Recursion.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Contact </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor@Recursion.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>rxrx-20250708.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 7/8/2025 4:17:12 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:rxrx="http://www.recursion.com/20250708"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.recursion.com/20250708"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20250708_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20250708_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>rxrx-20250708_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 7/8/2025 4:17:12 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>rxrx-20250708_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 7/8/2025 4:17:12 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="rxrx-20250708.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g83626g0707151441952.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g83626g0707151441952.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  8 $$# 2(  A$! Q$!_\0
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D?R""!^-%%%]+>@W%<U_4\0^S3_\ /&3_ +X-%%%=-SS['__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g83626g99t49.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g83626g99t49.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $5V82!097)E
M>B!'86UB;V$    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,R
M-   DI(  @    ,R-   ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MW'D_.I8'GH"V.U=WXC\>VWAWQAHGA^:REFEU=PJ3(X"QY;;R._6I_'7CC3O
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144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 08, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001601830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul.  08,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RECURSION PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4099738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">41 S Rio Grande Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(385)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">269 - 0203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Class&#160;A Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RXRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d83626d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d83626d8k.htm">d83626d8k.htm</File>
    <File>rxrx-20250708.xsd</File>
    <File>rxrx-20250708_lab.xml</File>
    <File>rxrx-20250708_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d83626d8k.htm": {
   "nsprefix": "rxrx",
   "nsuri": "http://www.recursion.com/20250708",
   "dts": {
    "inline": {
     "local": [
      "d83626d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "rxrx-20250708.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rxrx-20250708_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rxrx-20250708_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-07-08_to_2025-07-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d83626d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-07-08_to_2025-07-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d83626d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.recursion.com//20250708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-25-156440-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-156440-xbrl.zip
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MF7=# &,3&D%,"Y83<7=?W)$^"\08=PX?XOZ2E0&0JB$I1$4&/$"EX1(T*&&
M*7PL"T@^2H.$ADRD,I@0";9$#B9J!M-!](%C&J )/;639TMA')"J<&*?#40
M1&(_C,<Y(F*Y_W1E*YM4>JJD4<.IZ.>IHCR--)NNFDIGK16\E>:E>-H_'2Q'
MUBB52_S1[S%/8!\Q\DA# Z'EHU,I?2&"/H4]3$#B'->QJ\X:[.VTVP>S?N-^
M$8->ER,/I"@"Y-'V>F8RPRM@CLLL$CGUL6X*8M5N;AF13HIE*:Q&;31V2.=3
MES1;]2HTS(.K17'*FYP_A9SWP)I[L OA]1<PA& -@^<3\L9?6<AS1L'0FE.S
M$K[28S3:M-)H6J>1*T.A,&M58>5HS7:]JD?,(_LWK7D!K;F,&7H&/,*H3J.@
MPX\O!H,'A ]K:T_SKZP]*T49.%KQ')9:%5GE4];0.+_2W.AO/JW.Z3'?M.XU
MM>Y4RI3%+Z)[K3?=>Y#NM5BEO>$]K>Z9,=?6O2</(1W@JF,U%D.T%\V>!M-:
MW$!+80,X6.XSQ&MOAP"^IT, LR7"-?(H"U8PHP2/*LX]1T'L"F\6Z<-ZWI!X
M 97R2>IB#^;9]U:]O(HI*N*K5R[E9 2/-N33E"U?97N>@RWGYGB;$E]FW)(N
MN8<$] ^^S:U\T=E\+V>'%L;VVE%-&LV^TM*'ES9VVZ6C#JJV%H=C@C@,^--+
MA'=3)A&-R2T-4D9^K%=Q[QLDPCM7P[GG@EZF8+Z(*48=>TH;'L&1K=)1]X_N
M']_;\NR>6X#UH'.KT[@8U6+F\-?N-BJ/].DW\CD0 )L!]@0 ?,@7&M_,*Z:_
M)$8[#7W$K8ST)\13*7\8\0;TF:GC-5-Y=BX) $_ OCCI-;F.Q3@9(OR-,/=.
M)?'9@(?ZK*O.9-:W+**;2F/J0_4M+ IMX!;O'*B$IFW/U4'9" _*8I,U872S
M7\ER1K/3SCO4OWI02QU"ZIGQ'3*KBQW7[A,4_QS95E6ATM')@FU84?>WW3ZK
M7AW=Z?DBPITE$>%S5DM!M =+A!4+N',EG\\4EX8@UTIA0:Y#H>*65#+5"AAF
M2EAXRYVKZI2^@XH,4G,%$YQ\S&%JW)P0Z(,G,;OE$OJ!MM#0PQ0I]3P\BHJ-
M\;Z[3V-?ZN*5OS1H:FW0+&AR!;Q*,K8_QV6MO]6-U4)-]=V[^3+)1C,BB5\Y
M<*;/8-,!S@1C.I&(UH!I[PZ'&?*!,%+$^S_LJ7\'=CW1G1LJ>@&C,?J^H0K&
MWJTH7#_MG>1W+W>("]0S82,\7U%O',">-JOD:^AD"7HT8.K(SLFW%(R68\:K
M9+'A6..&W6J[<1$2O*FD!<1<5RJ3KGTA"+D$M#8"#Y$J^"'+Y#3TJF0#%1#7
MTZP?&*.J/C4.-LN@F-+C>,B0DG_#CS2&&4]UQS(:*;1%,4*"\5 $P:0BQNA$
M9=H'?,QIG)6US<#H,=5$']()..E>VL^GZH(1GO2Y@+;9&=BLO7V8-P=+DW<Y
MO?Q0)F=G'?AZ&259>W?-@&D"%N<#*P%52 !,%B5?&!Z;D4,>P:KQB4S(91J#
MO0)3>GP=,Y50*XPX^]B.7B7NE4+L,MNV3,3<?<Q8!A871 M)W*K_9!G,,57J
M*ZZ(-%&&6!6R<NJYH5X6:)VS/&FI52P[*6P\\#C;DY/SR\L&^>>_L^:#6(P,
M=$&6(I:RX9;V*E0.%84J;%!*4@@Y/!UR2 PY9@3'W3'5/9L6O-P@C17J\YGT
M8MX'1NBS'FZO8^2:=G7.=H#+B^U>>(&0ZL2&S>1E'<H%6JS0!Q,R9$%A&^;R
M&XV!X565' ,2!2\JTR"9.Y%M:2#K/15LF8UY&G#R-<OPPO)&TLX_3XYA8R!N
M3! D $C#B-EH-0K#S,*-U)-,X%V61Q1<H"-:C7)[:Z>\M]74LJ,EHK#=IR%7
M,Q>%I0Q"&'AI0!$3 7X"+\25HORX4]ZJU\O@8?%KFD>W>/324_F#'[>JC7:[
M638Y ]@?G.Y6!  +B?80J($0WH%GS;NI9:"8D^42+FX-7R7>A54<LR<]$QW1
M$A_<,]@G]7O!2.RX/%,GT9PN1+MW@_O4F/E9I+G[!BJ*N65LAWN':EO<0-!L
M=<!JA,A/ L4)[BD@1?-@=M0JF)=LT+)3)UA'BEQBA(*::'+7D"D\I0?1-@6R
M0)I!&44(8J(P+0A%A'IE=1]V 1;C@PFY!=,1:?%0V-0J) J#/M_%F5\43XKD
MJO-@$47IT6<M<55&,MFW%(@W<WU+18).E8@^DC8MB8VF*XKWD[%U3.G]!0T;
MHR!%KK7$6]/:YEG.HDJ,6#*%*++]*FKB\UNJJ[D"E?D*$Z*@%M,$XR,4B\QQ
M J,2?+=(+A_X>JAXHO>=7L-PU\B F9U6H[GL'@'CE'=&Y8!A0O,B 1U9!0&*
M#!(F':680S88(VB+81SX5!2VQEYU3_F=#;XY150B$I V>)0[6H>B[&SPPGR?
ML@ K>GPH]G!!QSS3I-(EG&_J+[\K<C-AYJ,1\_&T:("BSCQ6?(P7M"2"-ZUS
MN+=FSPWXBM; =LIW,-1 4)8 3_?/(!ORA=[Q43K*->5*Y$%[HB9V"6$ZT"B:
MPY@9C BT]$%'J<\L6<:%+I6VL4@!V!A)4YU<RLH 0, #9H([YB":=A:4<O 8
MKZ;?$-F(*>5VU5'1.L(K,-,N+EM.D4^.QTDC8PR%!S&5>K\9;H!U,8,4<;)^
ME85T#]KCJ]%\:TBUT[1"#H0BC['0[#$PP9G;,;-GF%K2(#/U16SCB/^4K35[
M;.GS>.RE(_U2PKS7_+4X[C*[LJ@7]D#W^3+R8'<94U^Y4\:LESK^$&/&"K0[
M9E3"QF-EG0T0N>"F:\ *_(X0V:O?J9?H^PAEYV"V#;>4_A5E)7<#R[2KC$?#
MF0H#=*Y.::RZA*UC2> X+_IL# ; _P=!Y2:$$ !<-RX HU1U1 :IM0?(]:ES
MM%@J0L<$";["T@/KRH+!HCEA2HJ+5[N: J1+HRC0CS ,#I%/Z+@ )*PYHM(\
M8QF ^<P90>F1(51)DV+A26?F (JVW>WMY@;;W'2:YJEQE.(L>YC?(M565>>Q
MG!S9._+N+4WV'&DR&-NZL)-.%IEK*XR[;-$YJ ;:L:*-0\^?JHA*N5&M01 I
M#Q(,PM*L/JM%K(B\'Z+HY(:Q:'9@1W8S445/U_^/,70!'W&$W^@6(W5B"@.9
MA =Z+ .(::)0G;$#'J)M;0V733@$2 ]Z G!<BD#9Y9AI$P*,&ZD83C]!'0#P
M@HQ,8GU[')N8"$%1J,?6O57Y":)6:]K2X-J&OE;G%I[7-X4N'8&-=+F@F#AS
MF[\<KO^@O"GX*$PNY#XY9H#9)##3'&;+RF@V%X6?OIQ>'FL!$GB>4"-]O^!<
MS<:-8=46S\0LX!IMA3:*'BD!(!2%RM<,+90WVAMT<Z.YF5-18"W.Z8D8G:C0
M(#2_[:/40;TK0.:=8(L-U_M8A)<W-D<+T?X8=.4J)UR)$L8)2IR<S/3BC=8W
MD&8FQ:$5J2B >D3--@0SL99'P]>OH=(,=3,8^O2E?IN7(^L%.Z]FQ/M9YKJ?
MP]$,\!1Z&SBK\)E>[9PM\[FN<_$0U $=%?B3/LQ0W.ML8ZTJ 6 "U!RH.HMG
MU0<HM-]37U7L,37X_,)]SKBI7X/+[RA@EMBWI@%9][ZU%IK-97=#WN<@>4E"
M(0#Q"5H8L&DZRZ@8I*ZS@;808ZN+_!@4VO73R7I97(L=75E>/V/Y%/7GI06<
MG6J]407^7F-*$-?YZ2/YR"5F@@'*OT#%1G-M3KJ_B/YT<A^C4HFA H (\'0T
M# %S>Q:3.IDOK2+%UKC3=O,IGBG0 K&W5VUH%/LT H<JEK_'Q-91U.C(=X(<
M1VN9O2'Z90(#'F:O<L<,4,CE<"9B=TETPS>7567M Z#IVIPI6];D*1PPI#[&
M KZUZA@0^-:D(U@"RB(AM;84Z^:[:QX06>BWW<9Y7MQJZIB#K#B@1V64.>T#
M6L^U%S".U$25E871*^/NP@HRX.ZW*:QA(E)9!A,'+/-.TT<$R@:"X0K9G1)S
MO'N;9:$1;.FWUWF%>34$HV;*U[4\N\KR7"@6G-QJO_8J]6'7T"@Q7!@(^FHO
M9X8HUC[SGKVL9UZJP\I"J(Z,J EM<L29T)975.D% 9YZ:Z@I86>9O3P&-?.J
M4-0J4->%#KT\QEW7G/4JK>->UZKMAGHCT,I.YZ*JV=)JM? \Y>[.;G8MPN70
M?.)R1=3+'RO SFZYOE>N-P87P/IQ2N.)O7E@MN#>H?%LM*9]QMS]4]1H$D!U
M+:14=LH$=%D]KI &'X/F9<Y+SDM=+4U"SBWL@A8K(XU'+P!H"HS1LH)<P>@@
MPH'615]SY4+_!8C?]0J8^2ABTP(N762UGM^I(="*LO*OB'AH8-KO/) H69@.
M#CGY+(0/@>)0"\S/=!2!?@BL8Y7));XS'? !39Q*1\"N:8 )Y2)WN)4 9*NN
M7>0@8JO:> 5K"LH\IK%/SH2XP05DRB2?VY*ZJ4:/ICK@G(C4N,:<#DP>4WNP
M5,$&_8H0@RYT9 ??Z@RQBF4M(M"+JP1F<?F@ULKA)ICP:\1HZ IT+HMG\,.\
M?:*+Z:M1#A'VMAR04\["H3R'@+X!, A*/%"BXJ< S_OIY:JC)MF[+59E/)7E
MQ]A"1P,YAW3")-8A*S H$3&>3B(#F =<XJ>%;%!1J<F.Z*A/<928O^JA3R\*
M/(RHO;ZTG(T"&I8M$\UWF*><_@Z0!1C"Z6_!+G!\$U/"II_HUX),?]MG 6>W
M,XTCD:AC53.SZG)#FG=0^0G8DX#&NEBNC!B"M)P5JC2=8S:=(Q98X]&_QES>
MZ!V#>$%G^)5T*.9[JM8#8HPA!5A^8+X^GZ)R93Y7,9^]$8^^2$?H*!D&?.E\
M /Y)&?.Z8,5QASZ[ [I7;LQSF<$_:8([9ITD$$P^ 34BSN3=R/ITD4^#.5E(
M,+CH?5Z?D5 OZ\$L*SD.0USR?4.>1KT8\Z!PX[$<]BV%43.7_:]4O309/NL)
MY+UF^%?53N%:',6UA-[ !H;"?;\,;)?**FG4G$8J(ZE2.\7]*&?'Y&GQ-!(>
M\G4BI;(M:9FJCNGLA@H9%$\*-<JL_(B':?(T3T#',W[",;RNFUB<F':/]KYE
M]U__$.R>BF0^90?"'3>L(:C"",\?WFSXF]ED2X3LN5_$_>&B^_&D6^E<G)T=
M7_9.]NTO][N_?X]+N._>Z6NXZH=?,S_7N3B[L^#B[%[]Q2[.KGV%T.RLWA>(
MM>YY#6O-RUBVTT?EHA3JSZ\U&4;/D:F99=FWL,&#VL(G8*Q1H,+WI>9KOJQ\
MGN\!0/\\#(8)P>Y1HO_DG+_;VFYN^^QNJU$=)C#6Q</CF,,:771S\^^\4\W6
M*VU5!\\-ZH,L]]VJ#8/5%58L*#;(W>;_[%9B?OE%MW)OS^SEI:H4=+-*@<K8
MF!JQ19T+LG__L[O5J+>?<;,ZZI3N)9[R5?<RJ#XY\Y$FE*A\Y ;>-/!1AYP\
MP*GZ\[4$_WXM\<W?2=JL.AYLZ9N+WO#W7P5_S_V#C:>?SX^OOG9/>L^>>YR^
MQ.16Y]>N3KDU?G-9U<?['RH1X1>29?H,JX35ZB0X OP^&])@8(V4"HE- WUV
M!E,7.!SLS5#$L#!_[KVJ9>'H?2.%0WT-\_7"A?;B:$$+[[R H:@ *B18/X)8
M].J=O?S5.U.H^64LMN,X6FO\8:Z'.B\4D07>2SWZ/MQ7Z>C#9/^I7UMAF]_O
MU2XK;C??TP[59(V<TP2,"_F5)@/.@E=^?\O\EUH]#:-G%OIW7&1GR-F G&$)
MBERHOV\0ST$O2_[.VO:C(<QAK2_\"7P&9!P<_3]02P,$%     @ 9$+H6A5X
MK_RT"@  D"4   \   !D.#,V,C9D97@U,2YH=&W-6FUSVCH6_LX,_T%#MYUV
M!P@02 A)F"% "5L*#";-=K\)6X!NC<W:<BCWU^\CR3:& +EIDNYMITVPY7.>
M\_YBKF['7WOUJ]MVHU5/IZ[&W7&O76__.U?)%Z].]"=</@GODZN;0>L[N>DT
M![W!Z#IS?]L=MS/$&'_OM:\S-G=8;L[X;"YJ?==;4#M3)^D4GF\R1S"O?M7J
M?HL.K[@EYK5JOL*=#*$VGSD@P*8BH]@,HV,+ZLVXDQ/NLE98BDL2?IZX0K@+
M?6GJ.B+G\S]9K;CY/*4+;J]K8[Y@/NFS%1FY"PI.C5ZWT[_.>!)DIGYU4V__
MG/,)%P0"DZN3F_K5R;">X)\@7@+Q'3B/T&3J'YR)O[Q45*0^&S>]-FFV>SUC
MV&AV^YWK3"&C/@\;K5;T^;[;&M]>9XJ%POL,N1F,6NV1NAYBT%=RT'FO,33:
MM>B7HZ(F]5(%L$AR4YE":AEZE@A']?"75H2C4GP/U9R,6YL[W\*GM:0;Q-'!
M;0+E:G0=_XT2K"*)EG3&<A./T1\Y[OC<8C7ZX'*+/$NB^@XV&$6+A<O=KQUB
MC)K7F5GU]*QT-KNX$.6+_!_+F=3#^#K3&W0&&>79&_ [,H:6C.SY^)SDM^-/
MO^JXU6?Z[3VW?=<AA@OE.9QT7-?RN#D/$=/%\A+/^51PZ8= _7M0#3UWRGR?
MNPZU2=/UEJX'"*ZS$U)OBN&B JT$8DX,005+IPSA,2:RQ BX8 015OB=: QJ
M"]*C/QAI<K'.DKLQJ9:+Q>+SS%)\&8AQC5Q]'O3'<>:=0Q4Y?TE-5G/<E4<1
M-D\>J!:*N3+^52M%:%">KL<_AENQCA\RZ1W0L<JBKY7%HUSVK\!>:]^O9DFI
M4*J0(PI^%03U$3,#3[HZ&<XI2IW) L%-:OM9TG7,/'F)E_T%]N4B,?)DQ%W2
M\:ACP=OSQV1^%9Z/G%G0N73G0G%7VE<IFJ]5_*1D6U5UM_KN5N=D-:Z'=<L7
M:YN1:W*H<F5V*R *^;XZH3N<$:LE"TKRWG8U2^B4;&N1O-2>E^01J!GWA<[8
M.GLN$%X$'YY,#I_1[&D3&KG3,"V0[;P0984W#<H>M3BNR(#H +LM):@="<6#
M7 7[*6!?"T1JY??/1-$09.T&'O'8?P/FH_:L&)G3!Q0C]A./.,PB8L[(87U+
M=3ZM=*BZ88PB;7_\S.&@3S[4=_/:4*>GI[E2M5P]KWZ*24A4']X5R^>7^[')
M>]7+3UG"'=,.+.[,E"!+S_67S!2!3RR<M,AG-O$"ZH4IN5C*IE,J*>O'M/@>
MXTZ2XPWU&1G&E&)64XAED<F:/)%PLX22%K/IBGJ,F)O>(\FCZ2Z6U%G'M%<<
M?8*\;4C:7$2^T_YISJDS0YYS%PNN&IH=,N'5D!($ TO' 7)Y-"*;3GE)-2X!
M/Z"PL'!WF39,V'U*BA>GIY #(*!MJ:<$4QR)<>/H#H&/>,AB4^5;$V:[JT_'
M*M#;N/U82GS J3U81N!X*#H\9NGZP.I.I\Q3.O<IW!=FEK=]9MO2N7SAFC_F
MKFWA3$(51GC;V-S>N(OG+H@ -,4*/[-;>A\%X%(N5DC@2**2)A2K=.XS ?D\
MF [6/!R?675OQUO3*2D"34:"'RR7MA9>!P58P&Z/.Y6$8!N":%>CQ[5H2D?"
MG3$9.AO'W<&AP>T22_I-L)1JH ZALQF\$\B4XV7+E?/L1:5$?,06\R,/2P3,
MV:5/FC;U?8V^ 8=?+%PGG5)&RI)_%/+HK=$*+*E''J@=P,I JNAM&R]RVA#6
M_\51MR+>4\XR@=_!EQY[T#[G..CHRDSSI$U^OWSWNMR0N-J@41%>(/'!0RS7
MC'XUF2?X%$E4A(G/8\B<%L)T3D54M9!7()J\9[,'A)'V=>0Z3'K(\5(M2N()
M];ER'%GZW"7&4@RG1"=Z.D6;#CQ+^!;"/H^,C0 QYR%$I<2X3$+?/A!:-62U
M3]K;)'V*H0ZPN8G>4['!=,/EH!D+%"M_QIP @CM@)D]2VR8^GX%- /Z7Y.,D
M019Y&Q(L)-$P.46$XV=C!G#V8(*C,IQQ&&$*US AJZ)J)JA"W6*.M&+"RZBY
M5L@0, AI$<.2Y[AB'LKO,:D?,%*?M3@H9^COE9\"J:"A/<.'GVG62,$>>^!L
MQ2R MF+0L/B1K!=F.&>M:Y/6MRKC4,3'33^ M"YR#%D=I5":,CZLRBV4J0!,
M  B!M3FWE8X!B^W"VIL:MR@R)^P5XN28J-X6\TV/3Z*.)1']J@)%+<ED#=[3
M'=[I5.*XXABE"E7V851.'9-IOA38H/D)RLQ='A/:E$$P.*DJ<5*;2"4Q,70K
MVD"A01&]CLR90A6,HV5H3Z+1->+C+.&&-C*\34R*%C",&NG/*A!P'?G9AY_E
M2</710'!3$W8%0[)/$[M="H*B2B<XQ . SO*%$BACBN(S%A+IM*6O2;H?:$(
M[L]EH4=1 ,TI9U8VX8<V/J,F03)7(L*IE2?CR]%*V(3U;FS(!#"%CT,$==]5
M=3%YZN%1&8LGY.6!"?E1(B8[:Y?DH/KV6[5HN]&X,\;=_H=WU>)%Y7+[Q\W
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MJ=:B.IZ\P(Z'V5E@;Z: G4%/P5,TCQ;!@PX<7I*M1:U2>;_M7+G2<[W+@'T
MR%YG_PYH3OP3\I>_.9 EPWSS;Z%$=+/&H$_PS^CVNZ0S&+1&W>;M%N2!T1AW
M?R5YO#+60U^!.-*#7YW([U3AHOHFUO\ 4$L#!!0    ( &1"Z%K-<O/AW0\
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M&;PTUR$#_@M->*.U>?:%^J!]B,;%6DNM_$B\S72NZJUZH*MTJ@T_@%8%\F7
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M@DX)JOB2*K(-I[^5'4U4)R$\E ;8!XLV":P,8($/1W>1OB;7D"RD6$;6@9
M.)(HE&ND]'N_5XB*P*C(]51%7&GS&V F5]P 8?0JBASR%$*VED:$(",==O[I
MDL]8,]1%41FB%)TTM9Q'\9VWZG]0Y\G68(FM\O3N-@EADGX"0U-2;%P+N6C5
M6 9Q:B>DDE+4R.48M-_S%C*"G:0-(XB7I(AZ2FL\24!DA"ZC;QZ=_HK/=6,
M)3__W2LA]Q:Y6H6,*NX@ABZ5<,1P F/>#"<*OE,[,I_+A=^@B4J:Y.1*7)_^
M Y;[?J,9EQL7.]\\YS\;XNWIT?CDQ<;VUM9?VM[ X?'Y^/CJ3[8N_CN:%^4#
M*[BS -%= 3+_1EU2QW&^W%98()PB25)$H++BZ.4P.NI4-5]+ 32IW\*RB#QB
MN*D#G\NZ_D:<API<&G5KK?,&:S*V;2QPDH<0UGPU$M-2ZL5<WRU,HL6I<;&]
M2RRSU,']WD-">.69.8BC\C%*;8DXQ-9CNJ8 3R ;&ZT 6AJPE2]_WKP\JM-Y
MH.SC*QW9B9Y+H$9)$*26TO@@NHDYL,,AO/N60N"B_[@[-5&Q.97<TYR"-'+0
M1+ $BLL$?'(L'2>[9<&!54FNBE)5@'1"+"4D:MA;$#_MC<@M+%IVTX0X2&LB
M2BCJ6 3>(J!3?C)*5B;EU%6S621O5H?<1H KE!L2O86H:.I\K7VG@,8<G]SW
MZ?G1L#%Q2^"H>N&7&F0$*>P2AFY4WF46)6>[^^#@A5B2)1VUZ17R5 JSY%-Z
M[,G6DQ\^GI\_E_P?(ZOYIGP^F#FE5D+Z"W8.WY#BC,VN[AIDLX8!%%A32<-7
M2+>S*(](*B>*%#5*NB"Y(%X4L2VB39)7'-[?_CAZ&L,/T^?D#MQ8E2 ,;(]Z
M%QQC) ](5:KV8C,8K>?;[2?K@U2E-??X&6I:U^5S%^LM/+AO(;Y=&ZPM(=M)
M";!8DE%<5SR$JACP'!AW$58W8CC IMHL,=9:=B2ZAF6!>9]U<SNG'MXL5\,4
MOPW"V87,F8:P#!(NTXKY%E(=,8NM"-05G9;:J6GM,EA.64B6>_?,B*VO.;19
M.O6"PDK#KNE&T+P-=%8KQ%4M\W6JZ#9=?(V4^&#SG*NIU;ZY6&^;=[,@TQSY
M[KY>.BE%SZQ%Z8H8EJ1Y0FIY 7IO4@ZU9 OM>3G:WVWK4:PU61%UC<Y#4ZJE
MU"+QQ ))9EB[4J>>^HPQ-BM;>3 T&!-!1-!K_3VW+D\;(.3$^)X[LZ73*E M
MW-'"%(!)IHHV!2$=(#UU90%W*2G'HKKF],7II9!)1@=F,)CC[IK,9Q @(2NX
M:$SI3@H%$B(P0K]7#\[<DN=U(-.*78QZ9KK88>-4A4*" YLZS6W]VCB@739<
ML$"1GL2,R6$-AV45D(";I6]:@ 4E?JRR0&ZF(%Z1)1Z;5RN:I"II$T5G97,L
M/9>3SH,>U]0-7-!JG[09GLBJ**O0M [O3F#GT6AT)E!2TY9+^*4/"\L=P+ER
MTPK/5[@G#@E,--'/?AYT? 6 44'-^&U0 \JKC398LQIW5;F;5_>?F;0P?Z%2
MC0I>?85*>&7M&6(/U:>C4R1FYVO0JCB3-TH<<EJ:4X\&:(J1/+55[5-53&(3
M$Y%\ O,/8I\CR"R6L#[A.M<W0;MH(7BKNEAGRB<)9KDO2GU)(UYC_>X[)1/8
M?E?F U[^>^MN!N(,VH0XG'O%F/'B \(8"0U%W4B<46#438P@YO/Y:)D"X,J!
M(*4:4QKEC7?B$3>%21:.Y]0+=_%@[$R;&Y6>FM8;_Z\]_^=KSU>Q*3\\L_:&
M(N :3*,B)WV=HI-:5C:I6)M1.@+S4G01@J,:XT0552?I(D<A.Y%4Y;%2C&<,
M]=G",*^WX=MMU'U^TGDUV15*,F/6_'A-L:19=)WAQRS.>D5@+E!W)JR*MI\_
M?]K1OK$:(4'"3<ZV\6L]99L95M+6O^W1BR(FD,EB60%WQ?3:V9K],_VZMD>[
MNS9<>Y[7J-N[!Z:KRFZWWV--#"63+&_IGB'6&KV^_Z,[X;/&?_.8L6T-QJTL
M%_+)&A+%P;!19DT-R04QK=CQ&5@5P)KJCI4(L_PR (-$NANUTEN.MX=XFL#'
M!=V"8:W\C#F<%+RMSV[;L&(\TTL%U*@F&02M0P].L4-JA#Z(9-;U\#3]H&?K
MF! ZY7-W1@02>4H]C"2C\B3&!D2A:<[SXA4Z7JZO]'OQ4BR75V^CIG>B 2JU
M>IWZ,B9=O3:! X&JU8NM;5<OUZJSO9E,Y6%7",Q8J7)K"*'4V3L9S%<3ZAT3
MIF[@;D/&J$S\Z+2_B:BB%T^XQ@D=F4M=WGCJ BM7U*5QRE=YJ!4F]WSI:-'%
M)C!KS1C., R=XH!NB'KH$"LJ"K;Q<H'="*!#!7)0<P 2[$[W=0%M2'QP*2K*
M3(+G$E4%QD![,!Q?.&FC=#V^:A327<T^@,'U0^?V2QVE'@5_%#XT!EF,GII*
MG9-<(]F$V.0GFVL)M*]-$/8D/*BHB:4.Y#^]7F+))'(*JQ'I51#9%A$L2SIX
M(;ZJN/3,9<+S^(H(4',?H*;"0=.((M$-&$>&\BQH8MQ04%B'<*+7722_@+/H
MO/$0#QR4R>(9'NY9+9_:@@@X7QO!3K@.1OU>'S(1B7:)4<8^H8ZGS_5Z$NM
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M+SHMMAB:LCY8ON1..S/0.N^"T1@2U)]N:)WBT$!E=G3DH"E+.S'>89HYQ-4
M9$_OSS0OE_";=J%Y#XO; 8A.>HN!N@JYG'_YM_Y>HX"6 !?"-PD?*Z(_2SW
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M<;Y[S.DAJ!T=)'#3_^>U,@ZG^'UN/0!EV:P;B/K)Q.AFP5G#FX:[>1T!66F
MFX^[@&G60H(S%8=4'>OF23O]EB%MTK0;J'\(FB2$37@<KUA^4T;:TEJ1W!&R
M]59X39 +O#6"2 3G%6"[A#/%+39>1KEI]VXXW_*(!C2A;/Y1K;@%]2-;EDV9
M'8%<8X)71;@@7*6&Q.^C/!3ZSO"VU7*9W$9]NV%[(XB>#Z*P2!\'TU\1$-=W
M=_8+ASJ%CC"V,,7W1;I@O4\5"6]5!LIU("L$:25GT-LV40;^F4Y0T;^4<D6$
M^P 8=%[&&%0;- _#3CSB2%1HMS486;E6YZ,E1[53TLB6X_*&!"NUGMH,1[,I
M32+K>QR[>5TM;:H,</-QIV6-40MK49.+@U*'5-Y]3=-*OULKF@9-NX$Z%;[^
MNNWM)IYQZR7XDZ2.$#6WS@T'7> T""&1F2M#)NU,90N-EI&T[1;GNGF^#A;*
M+6GR1+<YM^/KI]$(KX[!N([NZF%?2XL*.$]TM]>W\9IJV3S&YWOG,1%S-36_
M"OZ0+-1B9.FSAM]FK)#H]!.^>EM\;ZC[9WPULDBLYQ^,%84@JP1Y*:3/^%JT
M8?B0S]9+><>5VM*_=R+?1;/?OJ#V_ =02P,$%     @ 9$+H6B@F[5ZT!
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MHKW2/&*#O6]R?<0^V;L L>5O4$L! A0#%     @ 9$+H6@Q182Z[&   ?8(
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M,#(U,#<P.%]L86(N>&UL4$L! A0#%     @ 9$+H6B@F[5ZT!   ?2H  !4
M             ( !RCT  ')X<G@M,C R-3 W,#A?<')E+GAM;%!+!08
.!@ & 'L!  "Q0@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d83626d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rxrx-20250708.xsd" xlink:type="simple"/>
    <context id="duration_2025-07-08_to_2025-07-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2025-07-08</startDate>
            <endDate>2025-07-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-257">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-07-08_to_2025-07-08"
      id="Hidden_dei_EntityCentralIndexKey">0001601830</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-268">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-269">2025-07-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-270">RECURSION PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-271">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-272">001-40323</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-273">46-4099738</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-274">41 S Rio Grande Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-275">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-276">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-277">84101</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-278">(385)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-279">269 - 0203</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-280">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-281">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-282">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-283">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-284">Class&#160;A Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-285">RXRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-286">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-07-08_to_2025-07-08" id="ixv-287">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
